Skip To Main Content
Campus
  • Terapiområder
  • Materiell
Campus
  • Terapiområder
  • Materiell
View Full Results

Hudkreft

Ressurser

Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-­dosing, long-­term outcome of weight-­based dosing

Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-­dosing, long-­term outcome of weight-­based dosing

Les mer
Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis

Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis

Les mer